引用本文:[点击复制]
[点击复制]
【打印本页】 【在线阅读全文】【下载PDF全文】 查看/发表评论下载PDF阅读器关闭

←前一篇|后一篇→

过刊浏览    高级检索

本文已被:浏览 8144次   下载 180 本文二维码信息
码上扫一扫!
某三甲医院临床路径管理的应用效果评价
0
()
摘要:
目的 评价临床路径应用于7个有代表性单病种的临床效果。方法 用历史对照法选取单病种6 865例实施临床路径管理(路径组)和6 902例非临床路径管理(非路径组),对住院费用、住院时间、抗生素的使用费用等指标进行综合比较 、评价。结果 路径组与非路径组住院费用、住院时间和抗生素费用比较,P均﹤0.05,2组在3项评价指标上比较,差异有统计学意义(P﹤0.05)。结论 7个单病种的临床路径管理可以降低住院费用及抗生素费用,缩短住院时间。
关键词:  临床路径  单病种  住院费用  住院时间  临床效果
DOI:
基金项目:
The Application Result Evaluation of the Clinical Pathway in One Third-class Hospital
()
Abstract:
Objective Evaluation clinical pathway of the clinical results has been applied to seven representative monopathies. Methods Through selecting the monopathy management of 6 934 patients treated with the clinical pathway (the pathway group) and 6 896 patients receiving the routine treatment (the non-pathway group) by using history reference method, the indexes including the cost of hospitalization,the hospitalization time and the antibiotic expense etc have been compared and evaluated comprehensively.Results There is a statistics meaning of the difference(P<0.05) of two grouns which are the hospitalization cost of pathway group and non-pathway group,and in the comparision between hospitalization time and antibiotic cost,with both P<0.05.Conclusion It is a feasible method that the clinical pathway is used in 7 monopathies to degrade the hospitalization cost and the antibiotics expense disease ,and shorten the hospitalization time.
Key words:  clinical pathway, monodisease, hospitalization cost, hospitalization time, clinical effect

用微信扫一扫

用微信扫一扫